The objective of this research is elucidation of the molecular events in pituitary and nonpituitary tumor cells which regulate synthesis, storage, and secretion of polypeptide hormones, particularly, the hormones derived from pro-opiolipomelanocortin (POMC). We examined pheochromocytomas and normal adrenal medulla for the presence of immunoreactive (IR)-POMC peptides and the hypothalamic peptide, corticotropin-releasing hormone (CRH), that stimulates pituitary POMC secretion. We found all of the POMC peptides in normal and neoplastic adrenomedullary extracts. The ACTH in one pheochromocytoma was fully biologically active. We also found about equal parts of intact CRH and Met?21?-O-CRH. The intact CRH was full bioactive. None of pheochromocytoma patients had clinical evidence for ectopic ACTH or CRH production. The significance of the coexistence in the adrenal medulla of POMC peptides with CRH, their releasing hormone in the pituitary, and of the presence of POMC peptides adjacent to the adrenal cortex, whose function they help regulate, remains to be elucidated. However, our data do suggest that """"""""ectopic"""""""" production of ACTH by adrenomedullary tumors is more appropriately termed """"""""inappropriate."""""""" We have also determined the nucleotide sequence of cDNA to POMC mRNA from a cultured human small cell lung carcinoma line. The 795 bases code for all except the extreme N-terminus of POMC. With the exception of a conservative G-to-T base change, the sequence is identical to that of genomic POMC DNA from human placenta and fetal liver. Northern blot analysis reveals two mRNA species with approximate sizes of 1,300 and 1,550, as compared to 1,200 for human pituitary mRNA. The presence of higher molecular weight POMC mRNA has been noted in three other nonpituitary tumors. These data indicate that ectopic POMC and, presumably, other ectopic hormones represent inappropriate expression of normal genes. However, POMC mRNA may be incompletely or abnormally processed in tumor cells. (C)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA011685-16
Application #
3163519
Study Section
Endocrinology Study Section (END)
Project Start
1975-12-01
Project End
1986-11-30
Budget Start
1984-12-01
Budget End
1986-11-30
Support Year
16
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Dudley, Donald J; Drake, Joan; Quinlan, Jennifer et al. (2012) Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomarkers Prev 21:1639-44
Dickstein, G; DeBold, C R; Gaitan, D et al. (1996) Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. J Clin Endocrinol Metab 81:2934-41
Peterson, M E; Kemppainen, R J; Orth, D N (1994) Plasma concentrations of immunoreactive proopiomelanocortin peptides and cortisol in clinically normal cats. Am J Vet Res 55:295-300
Horiba, N; Nicholson, W E; Ch'ng, J L et al. (1993) Chromogranin A does not mediate glucocorticoid inhibition of adrenocorticotropin secretion. Endocrinology 132:1585-92
Gaitan, D; Loosen, P T; Orth, D N (1993) Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I. J Clin Endocrinol Metab 76:1580-2
Peterson, M E; Kemppainen, R J; Orth, D N (1992) Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency. Am J Vet Res 53:421-5
Peterson, M E; Greco, D S; Orth, D N (1989) Primary hypoadrenocorticism in ten cats. J Vet Intern Med 3:55-8
Debold, C R; Jackson, R V; Kamilaris, T C et al. (1989) Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man. J Clin Endocrinol Metab 68:431-7
Malchoff, C D; Rosa, J; DeBold, C R et al. (1989) Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome. J Clin Endocrinol Metab 68:855-60
DeBold, C R; Mufson, E E; Menefee, J K et al. (1988) Proopiomelanocortin gene expression in a pheochromocytoma using upstream transcription initiation sites. Biochem Biophys Res Commun 155:895-900

Showing the most recent 10 out of 20 publications